MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy

Melanocortin therapy by using adrenocorticotropic hormone (ACTH) or non-steroidogenic melanocortin peptides attenuates proteinuria and glomerular injury in experimental glomerular diseases and induces remission of nephrotic syndrome in patients with diverse glomerulopathies, even those resistant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yingjin, Berg, Anna-Lena, Wang, Pei, Ge, Yan, Quan, Songxia, Zhou, Sijie, Wang, Hai, Liu, Zhangsuo, Gong, Rujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897792/
https://www.ncbi.nlm.nih.gov/pubmed/27270328
http://dx.doi.org/10.1038/srep27589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897792/
https://www.ncbi.nlm.nih.gov/pubmed/27270328
http://dx.doi.org/10.1038/srep27589

Ejemplares similares